NTCP Modeling of Subacute/Late Laryngeal Edema Scored by Fiberoptic Examination

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 3, 2009, Pages 915-923

  Rancati, Tiziana ^a   Fiorino, Claudio ^b   Sanguineti, Giuseppe ^c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Head and neck radiotherapy; IMRT; Laryngeal edema; NTCP

Indexed keywords

BEST FIT; CLINICAL DATA; CONCURRENT CHEMOTHERAPY; DOSE-VOLUME HISTOGRAMS; EQUIVALENT UNIFORM DOSE; FIT PARAMETERS; HEAD AND NECK RADIOTHERAPY; HEAD-AND-NECK CANCER; IMRT; LARYNGEAL EDEMA; LINEAR QUADRATIC; LOGIT MODELS; MAXIMUM LIKELIHOOD ANALYSIS; NORMAL-TISSUE COMPLICATION PROBABILITY MODELS; NTCP; PATIENT DATA; RADIATION THERAPY ONCOLOGY GROUPS; STEEPNESS PARAMETER; VOLUME EFFECT;

CHEMOTHERAPY; HOSPITAL DATA PROCESSING; MAXIMUM LIKELIHOOD ESTIMATION; PARALLEL ARCHITECTURES; PHYSICAL THERAPY;

RADIOTHERAPY;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; FOLLOW UP; HISTOGRAM; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; LARYNX EDEMA; MAXIMUM LIKELIHOOD METHOD; NASOPHARYNX TUMOR; OROPHARYNX TUMOR; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SCORING SYSTEM;

CARCINOMA, SQUAMOUS CELL; FIBER OPTIC TECHNOLOGY; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL EDEMA; LARYNGOSCOPY; LARYNX; LIKELIHOOD FUNCTIONS; MODELS, STATISTICAL; PROBABILITY; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY DOSAGE;

EID: 70349559780     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.04.087     Document Type: Article

References (37)

1. Garden A.S., Morrison W.H., Rosenthal D.I., et al. Target coverage for head and neck cancers treated with IMRT: Review of clinical experiences. Semin Radiat Oncol 14 (2004) 103-109
2. Mendenhall W.M., Morris C.G., Amdur R.J., et al. Definitive radiotherapy for tonsillar squamous cell carcinoma. Am J Clin Oncol 29 (2006) 290-297
3. Lee N., Puri D.R., Blanco A.I., and Chao K.S. Intensity-modulated radiation therapy in head and neck cancers: An update. Head Neck 29 (2007) 387-400
4. Sanguineti G., Gunn G.B., Endres E.J., et al. Patterns of locoregional failure after exclusive IMRT for oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 72 (2008) 737-746
5. Eisbruch A. Intensity-modulated radiotherapy of head-and-neck cancer: Encouraging early results. Int J Radiat Oncol Biol Phys 53 (2002) 1-3
6. Eisbruch A. Reducing xerostomia by IMRT: What may, and may not, be achieved. J Clin Oncol 25 (2007) 4863-4864
7. de Arruda F.F., Puri D.R., Zhung J., et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 64 (2006) 363-373
8. Eisbruch A., Schwarz M., Rasch C., et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 60 (2004) 1425-1439
9. Feng F.Y., Kim H.M., Lyden T.H., et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 68 (2007) 1289-1299
10. Dornfeld K., Simmons J.R., Karnell L., et al. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet and speech-related quality of life. Int J Radiat Oncol Biol Phys 68 (2007) 750-757
11. Rosenthal D.I., Lewin J.S., and Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 17 (2006) 2636-2643
12. Jensen K., Lambertsen K., and Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: Frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 85 (2007) 74-82
13. Levendag P.C., Teguh D.N., Voet P., et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship. Radiother Oncol 85 (2007) 64-73
14. Caglar H.B., Allen A.M., Othus M., et al. Dose to the larynx predicts for swallowing complications following IMRT and chemotherapy. Int J Radiat Oncol Biol Phys 69 Suppl. 1 (2007) S53-S54
15. O'Meara E.A., Machtay M., Moughan J., et al. Association between radiation doses to pharyngeal regions and severe late toxicity in head and neck cancer patients treated with concurrent chemoradiotherapy: An RTOG analysis. Int J Radiat Oncol Biol Phys 69 Suppl. 1 (2007) S54-S55
16. Doornaert P., Slotman B.J., Rietveld D.H.F., et al. The mean radiation dose to pharyngeal structures is a string predictor of acute and persistent swallowing dysfunction and quality of life in head and neck radiotherapy. Int J Radiat Oncol Biol Phys 69 Suppl. 1 (2007) S55
17. Fu K.K., Woodhouse R.J., Quivey J.M., et al. The significance of laryngeal edema following radiotherapy of carcinoma of the vocal cord. Cancer 49 (1982) 655-658
18. Sanguineti G., Prashant A., Eugene E., et al. Dosimetric predictors of subacute laryngeal edema. Int J Radiat Oncol Biol Phys 68 (2007) 741-749
19. Sanguineti G., Endres E.J., Gunn B., et al. Is there a "mucosa sparing" benefit of IMRT for head and neck cancer?. Int J Radiat Oncol Biol Phys 66 (2006) 931-938
20. RTOG protocol 0022. Phase I/II study of conformal and intensity modulated irradiation for oropharyngeal cancer. Available at: www.rtog.org.
21. Wheldon T.E., Deehan C., Wheldon E.G., et al. The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy. Radiother Oncol 46 (1998) 285-295
22. Bentzen S.M., Saunders M.I., and Dische S. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. Radiother Oncol 53 (1999) 219-226
23. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
24. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res 104 Suppl. 8 (1985) S13-S19
25. Deasy J., Niemierko A., Herbert D., et al. Methodological issues in radiation dose-volume outcome analyses: Summary of a joint AAPM/NIH workshop. Med Phys 29 (2002) 2109-2127
26. Niemierko A. A generalized concept of equivalent uniform dose (EUD). [abstract]. Med Phys 26 (1999) 1100
27. Jackson A., Ten Haken R.K., Robertson J.M., et al. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 31 (1995) 883-891
28. Gagliardi G., Bjohle J., Lax I., et al. Radiation pneumonitis after breast cancer irradiation: Analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys 46 (2000) 373-381
29. Schilstra C., and Meertens H. Calculation of the uncertainty in complication probability for various dose-response models, applied to the parotid gland. Int J Radiat Oncol Biol Phys 50 (2001) 147-158
30. Rancati T., Fiorino C., Gagliardi G., et al. Late rectal bleeding: Fitting late rectal bleeding data using different NTCP models: Results from an Italian multicentric study (AIROPROS0101). Radiother Oncol 7 (2004) 21-32
31. James F., and Ross M. MINUIT-a system for function minimisation and error analysis of the parameter errors and correlations. Comp Phys Comm 10 (1975) 343-367
32. Fung K., Yoo J., Leeper H.A., et al. Vocal function following radiation for non-laryngeal versus laryngeal tumors of the head and neck. Laryngoscope 111 (2001) 1920-1924
33. Fung K., Yoo J., Leeper H.A., et al. Effects of head and neck radiation therapy on vocal function. J Otolaryngol 30 (2001) 133-139
34. Amdur R.J., Li J.G., Liu C., et al. Unnecessary laryngeal irradiation in the IMRT era. Head Neck 26 (2004) 257-263 discussion 263-254
35. Fiorino C., Dell'Oca I., Pierelli A., et al. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother Oncol 78 (2006) 276-282
36. Fiorino C., Dell'oca I., Pierelli A., et al. Mucosa-sparing simultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy: A planning study. Stralhenth Onk 183 (2007) 497-505
37. Widesott L., Pierelli A., Fiorino C., et al. Intensity modulated proton therapy vs helicoidal tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys 72 (2008) 588-596